Fifth Third Wealth Advisors’s Pfizer PFE Stock Holding History

Fifth Third Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.95M	Sell	205,404 -12,748	-6%	-$333K	0.14%	114
2026 Q1	$6.13M	Buy	218,152 +47,010	+27%	+$1.25M	0.21%	93
2025 Q4	$4.26M	Buy	171,142 +22,405	+15%	+$565K	0.15%	111
2025 Q3	$3.79M	Buy	148,737 +3,696	+3%	+$91.2K	0.14%	111
2025 Q2	$3.52M	Buy	145,041 +24,756	+21%	+$577K	0.15%	111
2025 Q1	$3.05M	Buy	120,285 +31,766	+36%	+$831K	0.16%	101
2024 Q4	$2.35M	Buy	88,519 +14,233	+19%	+$386K	0.13%	106
2024 Q3	$2.15M	Buy	74,286 +19,820	+36%	+$578K	0.13%	113
2024 Q2	$1.52M	Buy	54,466 +16,956	+45%	+$467K	0.12%	120
2024 Q1	$1.04M	Buy	37,510 +11,269	+43%	+$313K	0.16%	99
2023 Q4	$755K	Buy	26,241 +10,045	+62%	+$304K	0.25%	90
2023 Q3	$537K	Buy	16,196 +10,211	+171%	+$361K	0.22%	98
2023 Q2	$220K	Buy	+5,985	New	+$233K	0.14%	133

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Fifth Third Wealth Advisors's PFE Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Pfizer (PFE) stake by 5.8% in Q2 2026, selling an estimated $333K and leaving 205,404 shares worth $4.95M. The position accounts for 0.14% of the portfolio, ranked #114.

Fifth Third Wealth Advisors first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.13M in Q1 2026. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Fifth Third Wealth Advisors held 205,404 shares of Pfizer worth $4.95M as of Q2 2026.
Fifth Third Wealth Advisors sold 12,748 Pfizer shares in Q2 2026, an estimated $333K.
Pfizer made up 0.14% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #114 holding.
Fifth Third Wealth Advisors first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
Fifth Third Wealth Advisors's Pfizer position peaked at $6.13M in Q1 2026.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.